Galectin Therapeutics
GALT
#8729
Rank
HK$1.35 B
Marketcap
HK$20.53
Share price
-2.24%
Change (1 day)
109.38%
Change (1 year)

EPS for Galectin Therapeutics (GALT)

EPS in 2025 (TTM): -HK$4.52

According to Galectin Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$4.55. In 2024 the company made an earnings per share (EPS) of -HK$5.96 a decrease over its 2023 EPS that were of -HK$5.80.

EPS history for Galectin Therapeutics from 2001 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$4.52-24.12%
2024-HK$5.962.7%
2023-HK$5.8013.85%
2022-HK$5.0925%
2021-HK$4.0826.83%
2020-HK$3.215.13%
2019-HK$3.062.63%
2018-HK$2.98-22.45%
2017-HK$3.84-35.53%
2016-HK$5.96-13.64%
2015-HK$6.9012.82%
2014-HK$6.11-40%
2013-HK$10.1980.56%
2012-HK$5.64-32.08%
2011-HK$8.3113.98%
2010-HK$7.29-22.5%
2009-HK$9.41185.71%
2008-HK$3.29-70.83%
2007-HK$11.29118.18%
2006-HK$5.17-54.17%
2005-HK$11.29-14.29%
2004-HK$13.1747.37%
2003-HK$8.93-13.64%
2002-HK$10.35-24.14%
2001-HK$13.64

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Mirati Therapeutics
MRTX
-HK$95.78 2,006.90%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
HK$0.78-117.24%๐Ÿ‡บ๐Ÿ‡ธ USA